Persistent mTORC1 signaling in cell senescence results from defects in amino acid and growth factor sensing
What this study shows
Explains why mTORC1 stays switched on in senescent cells. In human fibroblasts rendered senescent three different ways, mTORC1 is constitutively active and no longer responds to serum or amino acid withdrawal. The defect is upstream, not in mTORC1 itself: it is driven in part by depolarisation of the senescent plasma membrane, which leads to primary cilia defects and a failure to shut off growth-factor signalling, while increased autophagy and high intracellular amino acid levels may act to support the nutrient arm. Correcting these inputs restored sensitivity of the pathway and killed the cells, which frames persistent mTORC1 signalling as a survival dependency of senescent cells rather than a by-product of senescence.
Abstract
ShowHide
Mammalian target of rapamycin complex 1 (mTORC1) and cell senescence are intimately linked to each other and to organismal aging. Inhibition of mTORC1 is the best-known intervention to extend lifespan, and recent evidence suggests that clearance of senescent cells can also improve health and lifespan. Enhanced mTORC1 activity drives characteristic phenotypes of senescence, although the underlying mechanisms responsible for increased activity are not well understood.
Read the full abstract on PubMed →At a glance
ShowHide
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human fibroblasts made senescent by stress, replicative exhaustion or oncogene activation) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human fibroblasts made senescent by stress, replicative exhaustion or oncogene activation |
| Journal | Journal of Cell Biology |
| Year | 2017 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1083/jcb.201610113 · PMID 28566325 |
Where this study fits
How this study connects to the pathway map, open questions, people and other studies in the Atlas.
People in the Atlas
-
First author of the study showing why mTORC1 stays switched on in senescent cells, and co-author on G3BP–TSC and senescence-mitophagy work; her own lab studies how nutrient sensing breaks down in ageing cells.
-
Showed that where lysosomes sit inside the cell tunes mTORC1 activity to nutrient supply. His Newcastle lab found that senescent cells can no longer switch mTORC1 off when nutrients or growth factors are withdrawn, and studies how autophagy and mitophagy decline with age
-
Microscopy specialist who manages Newcastle University's Bioimaging Unit and has worked for many years on the signalling networks that keep senescent cells in their arrested state
-
Professor of Cellular Dermatology and Oncology at Newcastle University who studies autophagy in melanoma, and whose work on the autophagy protein AMBRA1 and the skin protein loricrin underlies a test, developed with AMLo Biosciences, to identify early melanomas at low risk of spreading
-
Cell-senescence researcher who co-authored the Newcastle studies on stuck-on mTORC1 in senescent cells and on loss of basal mitophagy as a driver of cellular ageing.
More: 9 other authors
No profile yet: Rabanal-Ruiz Y, Kucheryavenko O, Dunhill-Turner NA, Chesterman CC, Zahari Q, Zhang T, Conduit SE, Mitchell CA, Maddocks ODK
Related studies
- A Impaired Chaperone-Mediated Autophagy Accelerates Intervertebral Disc Degeneration by Inducing MIDN Accumulation to Target TSC2 for Proteasomal Degradation
CHEN2026C · 2026 · Shares: Cellular senescence, mTORC1
- H Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial
CHU2019 · 2019 · Shares: Cellular senescence, mTORC1
- A Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK
YAN2026B · 2026 · Shares: Cellular senescence, mTORC1
- M mTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation
LAB2015 · 2015 · Shares: Cellular senescence, mTORC1
- M Rapamycin decelerates cellular senescence
DEM2009 · 2009 · Shares: Cellular senescence, mTORC1
More related studies
- A Rapamycin Attenuates Age-Related Changes in Marmoset Submandibular Gland: A Non-Human Primate Model of Human Oral Aging.
ABD2026 · 2026 · Shares: Cellular senescence
- A mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells
CHE2009 · 2009 · Shares: Cellular senescence
- A An ANGPTL8-AKT2-mTOR Axis Drives Adipose Senescence and Aging-Related Functional Decline
HE2026 · 2026 · Shares: Cellular senescence
- A Therapeutic Immune Reprogramming by Rapamycin Attenuates Plaque Inflammation and Lymphoid Immune Responses in Aged Atherosclerotic Mice
JIN2026C · 2026 · Shares: Cellular senescence
- H Rapamycin Exerts Its Geroprotective Effects in the Ageing Human Immune System by Enhancing Resilience Against DNA Damage
KEL2026 · 2026 · Shares: Cellular senescence
- M LINP1 suppresses radiation-induced cellular senescence in keratinocytes by modulating the mTOR-p53 axis
LIANG2026 · 2026 · Shares: Cellular senescence
- S Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials
TRI2026 · 2026 · Shares: Cellular senescence
- A
Topics
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Senescence induction (oxidative stress, replicative exhaustion, oncogene activation); serum and amino-acid starvation; correction of membrane depolarisation and cilia defects |
| Target | mTORC1 growth-factor and amino-acid sensing inputs |
| Model | Human fibroblasts |
| Effect | Senescent human fibroblasts keep mTORC1 constitutively active and starvation-resistant, and restoring pathway sensitivity killed the cells, suggesting persistent mTORC1 signalling supports senescent-cell survival. |
Thank you. Your answer was counted anonymously.